Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
Clinical trial NCT00527943 · TERMINATED
Trial details
- NCT number
- NCT00527943
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2011-07-01
- Enrollment
- 12944
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.